Company research
ALEXION PHARMACEUTICALS, INC.
CIK 899866Updated Sep 25, 2026
Securities
Historical securities (1)
ALXN · NASDAQ · equity · closed Jul 21, 2021Name history
ALEXION PHARMACEUTICALS INC · through Jun 29, 2018
ALXN price & chart
Historical security
This listing closed Jul 21, 2021. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2020 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 18,103,000,000Source | 17,544,600,000Source | 13,931,900,000Source | 13,583,300,000Source |
| Property, Plant and Equipment, NetUSD | 1,238,800,000Source | 1,163,300,000Source | 1,471,500,000Source | 1,325,400,000Source |
| GoodwillUSD | 5,100,100,000Source | 5,037,400,000Source | 5,037,400,000Source | 5,037,400,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 3,002,400,000Source | 3,344,300,000Source | 3,641,300,000Source | 3,954,400,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,964,500,000Source | 2,685,500,000Source | 1,365,500,000Source | 584,400,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 1,409,300,000Source | 1,243,200,000Source | 922,300,000Source | 726,500,000Source |
| Inventory, NetUSD | 862,300,000Source | 627,600,000Source | 472,500,000Source | 460,400,000Source |
| Assets, CurrentUSD | 5,833,000,000Source | 5,076,400,000Source | 3,385,000,000Source | 2,953,900,000Source |
| Operating Lease, Right-of-Use AssetUSD | 223,100,000Source | 204,000,000Source | — | — |
| Other Assets, NoncurrentUSD | 506,200,000Source | 429,000,000Source | 396,700,000Source | 312,200,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 6,451,800,000Source | 6,272,800,000Source | 4,766,600,000Source | 4,690,200,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Retained Earnings (Accumulated Deficit)USD | 5,243,200,000Source | 4,639,800,000Source | 2,325,800,000Source | 2,242,100,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -124,600,000Source | -66,800,000Source | -9,700,000Source | -34,400,000Source |
| Stockholders' Equity Attributable to ParentUSD | 11,651,200,000Source | 11,271,800,000Source | 9,165,300,000Source | 8,893,100,000Source |
| Additional Paid in Capital, Common StockUSD | 9,152,900,000Source | 8,804,700,000Source | 8,539,100,000Source | 8,290,300,000Source |
| Liabilities and EquityUSD | 18,103,000,000Source | 17,544,600,000Source | 13,931,900,000Source | 13,583,300,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 1,624,700,000Source | 1,194,300,000Source | 1,174,000,000Source | 952,500,000Source |
| Operating Lease, Liability, CurrentUSD | 28,100,000Source | — | — | — |
| Accounts Payable, CurrentUSD | 118,600,000Source | — | — | 70,800,000Source |
| Operating Lease, Liability, NoncurrentUSD | 177,100,000Source | 164,100,000Source | — | — |
| Deferred Income Tax Liabilities, NetUSD | 1,632,200,000Source | 2,081,400,000Source | 391,100,000Source | 365,000,000Source |
| Other Liabilities, NoncurrentUSD | 298,800,000Source | 265,600,000Source | 155,600,000Source | 140,200,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 1,084,700,000Source | — | — | 639,400,000Source |
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD | — | 9,200,000Source | 2,600,000Source | 4,800,000Source |
| Deferred Revenue, CurrentUSD | — | — | — | 15,900,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | 289,200,000Source | 272,400,000Source |
| Long-term Debt, Current MaturitiesUSD | 142,400,000Source | 126,700,000Source | 93,800,000Source | 167,400,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 2,419,600,000Source | 2,375,000,000Source | 2,501,700,000Source | 2,720,700,000Source |
cash flow · annual statements
| Line item | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 329,400,000Source | 376,800,000Source | 405,300,000Source | 496,700,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 281,100,000Source | 237,000,000Source | 203,000,000Source | 243,100,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 139,400,000Source | 319,200,000Source | 208,800,000Source | 55,200,000Source |
| Increase (Decrease) in InventoriesUSD | -95,000,000Source | 156,900,000Source | 14,700,000Source | 88,200,000Source |
| Deferred Income Tax Expense (Benefit)USD | -283,400,000Source | -455,500,000Source | 32,900,000Source | -45,900,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 3,002,900,000Source | 2,084,900,000Source | 426,000,000Source | 1,115,600,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 2,111,900,000Source | — | — | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -2,099,500,000Source | 9,700,000Source | 470,500,000Source | -918,300,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | 0Source | 100,000Source | -2,800,000Source | -100,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 106,700,000Source | 154,700,000Source | 213,000,000Source | 357,300,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 510,800,000Source | 416,000,000Source | 85,000,000Source | 463,600,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -611,900,000Source | -739,100,000Source | -102,400,000Source | -596,600,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | -29,200,000Source | -5,000,000Source | -20,900,000Source | -10,900,000Source |
| Repayments of Long-term DebtUSD | 130,600,000Source | 98,000,000Source | 293,800,000Source | 175,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 311,000,000Source | 1,356,300,000Source | 782,900,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 3,034,600,000Source | 2,723,600,000Source | 1,367,300,000Source | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 99,900,000Source | 72,600,000Source | 90,900,000Source | 95,300,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 281,100,000Source | 237,000,000Source | 203,000,000Source | 243,100,000Source |
| Amortization of Debt Issuance CostsUSD | — | 5,000,000Source | 8,000,000Source | 9,200,000Source |
| Amortization of Intangible AssetsUSD | 257,600,000Source | 315,000,000Source | 321,100,000Source | 320,200,000Source |
| Capitalized Computer Software, AmortizationUSD | 16,400,000Source | 15,300,000Source | 17,400,000Source | 16,000,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 5,200,000Source | 2,100,000Source | -4,800,000Source | 300,000Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | -6,400,000Source | 16,500,000Source | 15,800,000Source | — |
| Gain (Loss) on Disposition of AssetsUSD | 14,800,000Source | — | — | — |
| Gain (Loss) on Sale of InvestmentsUSD | 0Source | 32,800,000Source | — | — |
| Gain (Loss) on Disposition of Other AssetsUSD | 14,800,000Source | — | — | — |
| GoodwillUSD | 5,100,100,000Source | 5,037,400,000Source | 5,037,400,000Source | 5,037,400,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 2,053,300,000Source | 0Source | 0Source | 31,000,000Source |
| Income Tax Expense (Benefit)USD | -34,400,000Source | -225,500,000Source | 164,600,000Source | 104,500,000Source |
| Inventory Write-downUSD | 27,500,000Source | — | — | — |
| Investment Income, InterestUSD | 44,700,000Source | 100,300,000Source | 65,300,000Source | 18,500,000Source |
| Net Income (Loss) Attributable to ParentUSD | 603,400,000Source | 2,404,300,000Source | 77,600,000Source | 443,300,000Source |
| Operating ExpensesUSD | — | 2,476,200,000Source | 3,487,300,000Source | 2,469,500,000Source |
| Other Nonoperating Income (Expense)USD | -3,300,000Source | 35,900,000Source | 5,500,000Source | — |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | 0Source |
| Proceeds from Stock Options ExercisedUSD | 58,700,000Source | 29,900,000Source | 47,300,000Source | 85,900,000Source |
| Unrealized Gain (Loss) on InvestmentsUSD | -3,000,000Source | 26,900,000Source | 40,200,000Source | — |
income statement · annual statements
| Line item | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|
| Total RevenueUSD | 6,069,900,000Source | 4,991,100,000Source | 4,131,200,000Source | 3,551,100,000Source |
| Cost of RevenueUSD | 553,500,000Source | 394,500,000Source | 374,300,000Source | 454,200,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 1,399,900,000Source | 1,261,100,000Source | 1,111,800,000Source | 1,094,400,000Source |
| Operating Income (Loss)USD | 632,300,000Source | 2,120,400,000Source | 269,600,000Source | 627,400,000Source |
| Other Nonoperating Income (Expense)USD | -3,300,000Source | 35,900,000Source | 5,500,000Source | — |
| Income Tax Expense (Benefit)USD | -34,400,000Source | -225,500,000Source | 164,600,000Source | 104,500,000Source |
| Net Income (Loss) Attributable to ParentUSD | 603,400,000Source | 2,404,300,000Source | 77,600,000Source | 443,300,000Source |
| Earnings Per Share, BasicUSD per share | 2.74Source | 10.77Source | 0.35Source | 1.98Source |
| Earnings Per Share, DilutedUSD per share | 2.72Source | 10.7Source | 0.35Source | 1.97Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 220,100,000Source | 223,200,000Source | 222,700,000Source | 223,900,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 222,000,000Source | 224,800,000Source | 224,500,000Source | 225,400,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 257,600,000Source | 315,000,000Source | 321,100,000Source | 320,200,000Source |
| Business Combination, Acquisition Related CostsUSD | 117,600,000Source | — | — | 0Source |
| Capitalized Computer Software, AmortizationUSD | 16,400,000Source | 15,300,000Source | 17,400,000Source | 16,000,000Source |
| Costs and ExpensesUSD | 5,437,600,000Source | — | — | — |
| Current Income Tax Expense (Benefit)USD | 249,000,000Source | 230,000,000Source | 131,700,000Source | 150,400,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 5,200,000Source | 2,100,000Source | -4,800,000Source | 300,000Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | -6,400,000Source | 16,500,000Source | 15,800,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -1,098,500,000Source | 2,000,000Source | -451,400,000Source | -43,900,000Source |
| Interest ExpenseUSD | 104,700,000Source | 77,800,000Source | 98,200,000Source | 98,400,000Source |
| Investment Income, InterestUSD | 44,700,000Source | 100,300,000Source | 65,300,000Source | 18,500,000Source |
| Operating ExpensesUSD | — | 2,476,200,000Source | 3,487,300,000Source | 2,469,500,000Source |
| Research and Development ExpenseUSD | — | 886,000,000Source | 730,400,000Source | 878,400,000Source |
| Restructuring and Related Cost, Incurred CostUSD | 16,700,000Source | 17,200,000Source | 52,200,000Source | 287,400,000Source |
| Sales Revenue, Goods, Net (Deprecated 2018-01-31)USD | — | — | — | 3,549,500,000Source |
| Revenue, Net (Deprecated 2018-01-31)USD | — | — | — | 3,551,100,000Source |